Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm plus

Tarek El‐Toukhy, T El-Toukhy, S. Chandakas, Themos Grigoriadis, T Grigoriadis, N. Hill, J. Erian
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2004 · vol. 24(6) , pp. 680–683 · doi:10.1080/01443610400008024 · PMID:16147611 · W2117536581
Non-randomised trial OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study found that Cavaterm™<i>plus</i> endometrial balloon ablation in 220 patients successfully reduced menorrhagia in 74-83% of cases with high patient satisfaction and no complications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The objective of this prospective study was to evaluate the effectiveness of day-case Cavaterm plus thermal balloon endometrial ablation in the treatment of therapy-resistant menorrhagia. The study included 220 patients with a mean age of 41 years, mean parity of 2.1 and mean duration of menorrhagia of 3.2 years. A 6-mm diameter Cavaterm plus catheter with a silicone balloon at its tip was used. The ablation time was 10 minutes at a temperature of 78 degrees C. No procedure-related operative or immediate postoperative complications were encountered. The mean follow-up period was 19 months (range 6-24 months). The amenorrhoea-hypomenorrhoea rates at the various follow-up periods ranged between 74% and 83%. At the end of follow-up, 83% of patients were satisfied with the procedure. We conclude that Cavaterm plus is a safe and effective treatment for menorrhagia and has good patient acceptability.

My notes (saved in your browser only)

MeSH descriptors

Catheterization Menorrhagia Treatment Outcome Adult Catheterization Catheterization Catheterization Female Humans Menorrhagia Middle Aged Parity Patient Satisfaction

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (38)

Cited by (1)

SciLite annotations

chemicals 1
silicone macromolecule

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:03:18.265172+00:00
scilite
last seen: 2026-05-18T04:25:29.313245+00:00
unpaywall
last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0 · commercial use OK